Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001702309 | SCV002245987 | pathogenic | not provided | 2021-12-03 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC12A3 protein function. ClinVar contains an entry for this variant (Variation ID: 1285185). This missense change has been observed in individuals with Gitelman syndrome (PMID: 12112667). This variant is present in population databases (rs757792232, gnomAD 0.0009%). This sequence change replaces tryptophan, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 172 of the SLC12A3 protein (p.Trp172Arg). |
European Hospital Georges Pompidou Genetics Department, |
RCV002243433 | SCV002513869 | likely pathogenic | Familial hypokalemia-hypomagnesemia | 2022-04-27 | criteria provided, single submitter | clinical testing | ACMG criteria used:PS4, PM1, PM2, PM3, PP5 |
Gene |
RCV001702309 | SCV003842447 | pathogenic | not provided | 2023-03-15 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25841442, 14596636, Portioli2021[review], 22009145, 34426522, 31672324, 12112667) |
Genome Diagnostics Laboratory, |
RCV001702309 | SCV001929519 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001702309 | SCV001958463 | pathogenic | not provided | no assertion criteria provided | clinical testing |